Background. Inorganic¯uoride is released by the metabolism of en¯urane and the increased serum¯uoride concentrations may impair renal function. Tobacco smoke consists of numerous reactive compounds that can either induce or inhibit drug metabolism. Studies on the interaction of smoking with anaesthetic drug metabolism and possible toxicity are warranted.
Metabolism of en¯urane releases inorganic¯uoride but does not appear to be harmful in patients with normal renal function. Rarely inorganic¯uoride concentrations may reach the suggested renal toxic threshold (50 mmol litre ±1 ), 1 but impaired renal function has been reported after prolonged en¯urane anaesthesia. 2 Serum¯uoride concentration during en¯urane anaesthesia can be affected by other therapy. For example, concomitant treatment with isoniazid (inducer of hepatic drug metabolism) increases serum¯uoride concentrations 3 while disul®ram (inhibitor of drug metabolism) reduces¯uoride concentrations. 4 Enzyme induction by aminoglycosides can increase the nephrotoxicity of en¯urane, as indicated by excretion of urinary alanine aminopeptidase as a marker of proximal tubular function. pharmacological effects on the body. For example, nicotine and its main metabolite inhibit cytochrome P450 2EI (CYP2E1), 7 the isoenzyme responsible for de¯uorination of¯uorinated ether anaesthetics. 4 8 In addition, the polyaromatic hydrocarbons found in tobacco smoke are potent inducers of drug metabolism 9 and induction of liver enzymes in smokers increases the metabolism of antipyrine, 10 pentazocine 11 and theophylline. 12 We noted that plasma inorganic¯uoride concentrations seemed to be greater in smokers than in non-smokers after en¯urane anaesthesia. Because our knowledge of¯uoride metabolism in smokers is sparse, we designed this prospective clinical trial to determine whether smoking tobacco in¯uences serum concentrations of inorganic¯uoride after en¯urane anaesthesia. Serum creatinine, b 2 -microglobulin and tumour-associated trypsin inhibitor (TATI) were used to evaluate possible renal damage.
Materials and methods
The study was approved by the ethics committee of the Women's Hospital, University of Helsinki and was conducted in accordance with the Declaration of Helsinki. 13 Thirty-three women (ASA I±II) without pre-existing renal disease were enrolled. None of the patients used any concomitant medication known to modify cytochrome P450 activity. Seventeen smokers (more than 10 cigarettes daily) and 16 non-smokers underwent elective laparoscopic or open abdominal gynaecological operations. All patients were informed and gave written consent.
Anaesthesia was standardized. Diazepam 5±10 mg orally was used for premedication. The patients were given glycopyrrolate 0.2 mg and fentanyl 0.1±0.15 mg i.v., anaesthesia was induced with propofol 2.5 mg kg ±1 i.v., and tracheal intubation was facilitated with rocuronium 0.5 mg kg ±1 i.v. Anaesthesia was maintained with 1.3 minimum alveolar concentration (MAC) of en¯urane (the end-tidal concentration of en¯urane was set at 2.1%) in 33% oxygen±air mixture for 45 min, which corresponds to a 1 MAC-hour anaesthesia. A semiclosed breathing system with fresh gas ow of 3 litres min ±1 was used. The concentrations of inhalation gases and anaesthetics were monitored with a Datex AS/3 monitor (Datex-Ohmeda, Instrumed Corporation, Helsinki, Finland). The inhalation anaesthesia was discontinued after 45 min. Thus, all patients in both study groups were given 1 MAC-hour inhalation anaesthesia with en¯urane.
After cessation of en¯urane administration, the anaesthesia was continued with propofol infusion and the lungs were ventilated with oxygen 33% in nitrous oxide. Additional doses of fentanyl and neuromuscular blocking drug were given when needed.
Fluid therapy was standardized for the ®rst 24 h. Patients were given Ringer's solution 10 ml kg ±1 at induction of anaesthesia followed by an infusion of 5 ml kg ±1 h ±1 during surgery and in the recovery room. From the ®rst postoperative day patients were allowed to drink ad libitum. Venous blood samples for serum inorganic¯uoride were collected before anaesthesia and 1, 2, 3, 6 and 24 h after the end of en¯urane inhalation. Serum and urine samples for creatinine, b 2 -microglobulin and TATI were collected at induction and on the ®rst and second postoperative mornings. b 2 -Microglobulin is a marker of renal tubular damage 14 and TATI of glomerular ®ltration rate. 15 The urinary catheter was inserted after the induction of anaesthesia for urine sampling. The urine markers were measured from spot samples to prevent the confounding effect of different urine volumes. 16 The urinary catheter was removed when it was no longer clinically necessary.
The concentrations of inorganic¯uoride were determined by a method modi®ed from that of Fry and Taves. 17 In brief, a¯uoride-selective combination electrode (Orion model 96-09; Orion Research, Boston, MA, USA) was used for the measurement on Para®lm M (American National Can, Greenwich, CT, USA) placed on 16-mm cell culture wells. Before measurement, 200 ml of acetate buffer (acetate± NaOH 1 mol litre ±1 , pH 5.2, NaCl 1 mol litre ±1 ) and 10 ml of sodium¯uoride 20 mmol litre ±1 were added to 190 ml of serum. The sensitivity of this assay was approximately 0.5 mmol litre ±1 and the interassay coef®cient of variation was less than 8%.
The b 2 -microglobulin concentration was determined using time-resolved¯uoroimmunoassay (Del®a â ; Wallac, Turku, Finland). Urine TATI was analysed by radioimmunoassay (Orion Diagnostica, Espoo, Finland). Serum and urine creatinine were analysed using a kinetic Jaffe method. The reference limits of the hospital laboratory are for serum TATI 0±2 nmol litre ±1 , for urine TATI indexed to urinary creatinine 0±1.3 nmol mmol ±1 creatinine, and for serum and urine b 2 -microglobulin respectively 0.6± 3.0 mg litre ±1 and less than 0.25 mg litre ±1 .
Statistics
We estimated the required sample size from our pilot observations, which found that the mean serum inorganic uoride concentration was 12 (SD 4) mmol litre ±1 after en¯urane anaesthesia in non-smoking women. From these data we estimated that 15 patients in each group would provide 80% power to detect a 35% difference in inorganic uoride concentrations between the groups with a 0.05 level of signi®cance.
The area under the serum¯uoride concentration time curve from zero time to the 24 h blood sampling (AUC F mmol litre ±1 ) was calculated according to the linear trapezoidal rule.
Statistical analyses were with SPSS 9.0 (SPSS, Chicago, IL, USA). The c 2 -test was used for categorical variables. The independent samples two-tailed t-test was used to analyse values with a normal distribution (tested with Leaven's test), and for skewed data we used the Mann± Whitney U-test. The Friedman test was used to compare inorganic¯uoride concentrations observed over the different sample times. A P-value of`0.05 was considered statistically signi®cant. The data are expressed as mean (SD) and minimum±maximum unless otherwise stated.
Results
The characteristics of the two groups are shown in Table 1 . In the smokers group there were 13 moderate smokers (10± 20 cigarettes per day) and four heavy smokers (more than 20 cigarettes per day). No patients were withdrawn from the study. There were some minor protocol deviations, which were unlikely to have interfered with the results; blood samples for the determination of inorganic¯uoride were not obtained for one patient at baseline, for seven patients at 6 h and for seven patients at 24 h. All the other 183 samples were drawn according to the trial protocol.
Inorganic¯uoride concentration increased signi®cantly in both groups after 1 MAC-hour en¯urane anaesthesia (P<0.001, Friedman test) and was still increased at 24 h in both study groups (P<0.001, paired sample t-test). However, in the smokers the¯uoride concentration was signi®cantly greater than in the non-smokers (P<0.05) 1, 2, 3 and 6 h after en¯urane inhalation (Fig. 1) .
The greatest inorganic¯uoride concentration ranged between 8.4 and 21.0 (mean 13.8 (SD 3.4) ±1 ; P=0.028, Mann±Whitney U-test). Serum TATI and b 2 -microglobulin values did not differ between the two groups. Urine TATI and the b 2 -microglobulin±creatinine ratio remained at small values during the study period and serum creatinine remained at the baseline in both study groups during the ®rst 2 postoperative days ( Table 2 ).
Discussion
We found that the serum concentrations of inorganic uoride were signi®cantly greater in women who smoked compared with the non-smokers after 1 MAC-hour en¯urane anaesthesia. The concentration of¯uoride was greatest 2±3 h after anaesthesia and was still increased at 24 h in both study groups, although no signi®cant difference between the two groups was present after 24 h. No nephrotoxic effects were found: there were no changes in renal tubular reabsorption capacity and glomerular ®ltration assessed by serum and urine b 2 -microglobulin, TATI and serum creatinine measurements.
En¯urane is predominantly metabolized in the liver by cytochrome P450 2E1 isoform to inorganic¯uoride. 4 Tobacco smoke contains powerful inducers of cytochrome P450 enzymes and the induction of cytochrome P450 2E1 is the most likely reason for increased concentrations of inorganic¯uoride after en¯urane anaesthesia. However, the interaction between the components of tobacco smoke and anaesthetic inhalation agents is poorly investigated.
Inorganic¯uoride concentrations seldom reach the renal toxic concentration of 50 mmol litre ±1 during short inhalation anaesthesia. 1 In volunteers renal concentrating ability decreased when serum inorganic¯uoride was maximal at only 33.6 mmol litre ±1 after en¯urane anaesthesia. 18 In the present study, one woman in the smokers group had a serum uoride concentration of 38 mmol litre ±1 while the greatest concentration in the non-smokers group was 21 mmol litre ±1 . It is probable that it is not the maximum concentration but rather the duration of raised inorganic concentrations (i.e. the area under the curve) which may affect the development of nephrotoxic effects after en¯urane anaesthesia. 19 Also, other reactive intermediate metabolites may be potential nephrotoxins. For example, alkaline degradation of en¯urane produces halogenated alkenes that are conjugated further to possibly nephrotoxic thiol compounds. 20 Renal tubular function remained stable in this study, as indicated by serum and urine b 2 -microglobulin concentra- tions. The b 2 -microglobulin is a low molecular weight protein produced predominantly by lymphocytes. 14 It is ®ltered through the glomerulus and reabsorbed in the proximal tubules. Serum and urine b 2 -microglobulin concentrations increase in patients with tubular damage. Increased serum concentrations of b 2 -microglobulin have been measured in connection with high inorganic¯uoride concentrations after sevo¯urane anaesthesia. 21 Serum concentrations of b 2 -microglobulin are also in¯uenced by immunological and stress reactions, and infections, because of the predominant production in lymphocytes. In our study, a possible in¯uence of diurnal variation in serum b 2 -microglobulin concentrations, with peak values in the morning, 22 was minimized by sampling at the same time each morning. The urine markers were determined from spot samples and normalized to urinary creatinine. The use of spot samples may have affected the results, although this normalization to urine creatinine is commonly used to avoid the confusing effect of different urine volumes. 16 A small amount of TATI is found in the serum and urine of healthy subjects, and serum TATI concentration has a negative correlation with glomerular ®ltration rate. If glomerular ®ltration rate is reduced, serum TATI increases with increased urinary excretion. 15 In the present study thē uid therapy was standardized for the ®rst 24 h after surgery and thereafter the patients were allowed to drink ad libitum. This may have affected the urinary marker results. TATI is used as a tumour marker for conditions such as ovarian cancer. 23 This could have been a confounding factor in the present study.
We conclude that inorganic¯uoride concentrations are increased markedly in smokers compared with non-smokers after 1 MAC-hour en¯urane anaesthesia. Induction of cytochrome P450 enzymes by cigarette smoke is likely to be the cause. However, we did not ®nd¯uoride-induced nephrotoxicity. 
